Pure Global
NCT06408012

An Innovative Master Platform for Clinical Trials in Mood Disorders

Enabling Neuroscience Research Approaches for Brain, feeLings and Emotions (ENABLE): An Innovative Platform for Clinical Trials in Mood Disorders
St. Joseph's Healthcare Hamilton·ClinicalTrials.govRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Mood Disorders,Depressive Disorder,Bipolar and Related Disorders
Study type
Observational
Sponsor & location
Primary sponsor
St. Joseph's Healthcare Hamilton
Location
Calgary,Vancouver,Halifax,Hamilton,Kingston,Ottawa,Toronto,Toronto, Canada
Timeline & enrollment
Phase
N/A
Start date
Oct 17, 2023
End date
Mar 31, 2026
Enrollment
900 participants
Primary outcome

Rate of participation in the master trial platform

Summary

Mood disorders such as depression and bipolar disorder affect over 350 million people around
 the world. While several effective treatments exist, it is often difficult to match the right
 treatment to an individual person. Repeated efforts to find the right treatment contribute to
 poor functioning, low quality of life, and prolongs the time it takes to get well. Most areas
 of medicine are able to use 'biomarkers' or clinical tests, blood tests, or imaging to help
 diagnose and treat illness. The search for biomarkers in mood disorders is advancing, but one
 roadblock to progress is the lack of large, standardized studies of mood disorders that are
 needed to accurately identify biomarkers. The aim of the ENABLE platform is to provide the
 Canadian neuroscience community a standardized way of collecting biomarker data from
 individuals with a range of mood disorders symptoms. In addition, this 'master clinical trial
 platform' framework will provide a pool of participants who can be recruited into
 biomarker-based clinical trials.

ICD-10 classifications
Other bipolar affective disordersBipolar affective disorderMood [affective] disordersOther mood [affective] disordersBipolar affective disorder, unspecified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06408012
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06408012 through Pure Global AI's free database. This phase not specified trial is sponsored by St. Joseph's Healthcare Hamilton and is currently Recruiting. The study focuses on Mood Disorders,Depressive Disorder,Bipolar and Related Disorders. Target enrollment is 900 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.